Rachel Huddart
Stanford University(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices, Genomics and Rare Diseases, Biomedical Text Mining and Ontologies, CRISPR and Genetic Engineering
Most-Cited Works
- → An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine(2021)742 cited
- → Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy(2021)378 cited
- → Genome edited sheep and cattle(2014)272 cited
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update(2020)165 cited
- → Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research(2018)133 cited
- → Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT‐RNR1 Genotype(2021)100 cited
- → PharmGKB summary: sertraline pathway, pharmacokinetics(2019)72 cited
- → Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy(2024)59 cited
- → PharmGKB summary(2018)38 cited
- → Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?(2019)36 cited